Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study

Journal of Neural Transmission

Volumn 122, Issue 6, 2015, Pages 867-872

  Kocsis, K ^a,b   Knapp, L ^a   Meszaros J ^a   Kis, Z ^a   Farkas, T ^a   Vecsei L ^b   Toldi, J ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acetyl L carnitine; Brain ischemia; Hippocampus; LTP; Oxaloacetate

Indexed keywords

GLUTAMIC ACID; LEVACECARNINE; OXALOACETIC ACID; ACETYLCARNITINE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MEGADOSE; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; FIELD EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; WAVEFORM; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; HIPPOCAMPUS; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; TIME; TISSUE CULTURE TECHNIQUE; WISTAR RAT;

ACETYLCARNITINE; ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXALOACETIC ACID; RANDOM ALLOCATION; RATS, WISTAR; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 84930213160     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1343-7     Document Type: Article

References (23)

1. Borum PR (1983) Carnitine. Ann Rev Nutr 3:233–259. doi:10.1146/annurev.nu.03.070183.001313
2. Castillo J, Davalos A, Naveiro J, Noya M (1996) Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke J Cereb Circ 27:1060–1065
3. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623–634
4. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
5. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–397
6. Fukuchi T, Katayama Y, Kamiya T, McKee A, Kashiwagi F, Terashi A (1998) The effect of duration of cerebral ischemia on brain pyruvate dehydrogenase activity, energy metabolites, and blood flow during reperfusion in gerbil brain. Brain Res 792:59–65
7. Gottlieb M, Wang Y, Teichberg VI (2003) Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119–126
8. Jalal FY, Bohlke M, Maher TJ (2010) Acetyl-L-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats. Ann N Y Acad Sci 1199:95–104. doi:10.1111/j.1749-6632.2009.05351.x
9. Jones LL, McDonald DA, Borum PR (2010) Acylcarnitines: role in brain. Prog Lipid Res 49:61–75. doi:10.1016/j.plipres.2009.08.004
10. Kocsis K et al (2014) Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia. Neuroscience 269:265–272. doi:10.1016/j.neuroscience.2014.03.055
11. Lozano R et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380:2095–2128. doi:10.1016/S0140-6736(12)61728-0
12. Malaguarnera M et al (2011) Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 46:750–759. doi:10.3109/00365521.2011.565067
13. Marosi M et al (2009) Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol 604:51–57. doi:10.1016/j.ejphar.2008.12.022
14. Martin E, Rosenthal RE, Fiskum G (2005) Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res 79:240–247. doi:10.1002/jnr.20293
15. O’Kane RL, Martinez-Lopez I, DeJoseph MR, Vina JR, Hawkins RA (1999) Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 274:31891–31895
16. Picconi B et al (2006) Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 50:917–923. doi:10.1016/j.neuropharm.2006.01.002
17. Rani PJ, Panneerselvam C (2002) Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats The journals of gerontology Series A. Biol Sci Med Sci 57:B134–B137
18. Reed LJ (1981) Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle. Curr Top Cell Regul 18:95–106
19. Shuaib A, Waqaar T, Wishart T, Kanthan R, Howlett W (1995) Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem Res 20:1021–1025
20. Sims NR (1995) Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia. Metab Brain Dis 10:191–217
21. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301–308. doi:10.1016/j.neuroscience.2008.02.075
22. Zanelli SA, Solenski NJ, Rosenthal RE, Fiskum G (2005) Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. Ann N Y Acad Sci 1053:153–161. doi:10.1196/annals.1344.013
23. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI (2007) Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203:213–220. doi:10.1016/j.expneurol.2006.08.021